Prognostic significance of serum B-lymphocyte stimulator level in Hodgkin's lymphoma
暂无分享,去创建一个
Y. Oki | G. Georgakis | A. Younes | L. Kwak | T. Migone
[1] E. Cesarman,et al. The TNF Family Members BAFF and APRIL Play an Important Role in Hodgkin Lymphoma. , 2005 .
[2] T. Habermann,et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. , 2004, Blood.
[3] E. Schattner,et al. Lymphoma B Cells Evade Apoptosis through the TNF Family Members BAFF/BLyS and APRIL1 , 2004, The Journal of Immunology.
[4] F. Ajchenbaum‐Cymbalista,et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. , 2004, Blood.
[5] B. Harder,et al. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. , 2004, Blood.
[6] P. Schneider,et al. BAFF AND APRIL: a tutorial on B cell survival. , 2003, Annual review of immunology.
[7] J. D. Vos,et al. Survival and Proliferation Factors of Normal and Malignant Plasma Cells , 2003, International journal of hematology.
[8] R. Bram,et al. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. , 2002, Blood.
[9] V. Roschke,et al. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. , 2001, Arthritis and rheumatism.
[10] Olker,et al. A PROGNOSTIC SCORE FOR ADVANCED HODGKIN ’ S DISEASE , 2000 .